Dr. Malek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2001 - 2004
- Baylor College of MedicineResidency, Internal Medicine, 1997 - 2001
- University Hamburg, Krankenhaus Eppendorf, Fak MedClass of 1993
Certifications & Licensure
- MI State Medical License 2004 - 2026
- MD State Medical License 2001 - 2005
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL Start of enrollment: 2012 Nov 01
Publications & Presentations
PubMed
- Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.Qiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, Karan Bedi, Mohamed Rizk
Leukemia. 2024-11-13 - Big1 is a newly identified autophagy regulator that is critical for a fully functional V-ATPase.Yuchen Lei, Ying Yang, Zhihai Zhang, Ruoxi Zhang, Xinxin Song
Molecular Biology of the Cell. 2024-11-01 - Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.Qiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, Karan Bedi, Mohamed Rizk
Leukemia. 2024-10-25
Grant Support
- Genomic Complexity And Clinical Outcome In Chronic Lymphocytic LeukemiaNational Cancer Institute2009–2012
- Genomic Profiling And Clinical Outcome In Chronic Lymphocytic LeukemiaNational Cancer Institute2007–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: